All articles by Edit Kovalcsik

NICE’s head of scientific advice on pharma R&D in a personalised era

Fast-advancing science has opened up the era of targeted therapy and precision medicine, and as a result pharma’s business model may no longer be fit for purpose to effectively develop and bring to market new treatments.